# Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays

> **NCT01702103** · PHASE3 · UNKNOWN · sponsor: **PH&T S.p.A.** · enrollment: 360 (estimated)

## Conditions studied

- Nasal Obstruction
- Sneezing
- Itching

## Interventions

- **DRUG:** Mometasone furoate

## Key facts

- **NCT ID:** NCT01702103
- **Lead sponsor:** PH&T S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-03
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2012-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702103, "Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01702103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*